Company CannaPharmaRX, Inc. Other OTC
Equities
CPMD
US13765D1090
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dean Medwid
CEO | Chief Executive Officer | - | 01/23/01 |
Dominick Colvin
CEO | Chief Executive Officer | 55 | 01/17/01 |
Oliver Foeste
DFI | Director of Finance/CFO | 48 | 13/23/13 |
Andrew Steedman
COO | Chief Operating Officer | 62 | 23/19/23 |
John Cassels
AUD | Comptroller/Controller/Auditor | 75 | 23/19/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Orman
CHM | Chairman | 74 | 23/19/23 |
Dominick Colvin
CEO | Chief Executive Officer | 55 | 01/17/01 |
Anthony Panek
BRD | Director/Board Member | 39 | 25/23/25 |
Adam Mindle
BRD | Director/Board Member | 53 | 25/23/25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 344,191,897 | 335,074,320 ( 97.35 %) | 6,230,761 ( 1.810 %) | 97.33 % |
Stock B | 0 | 84,416 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+31.06% | 68TCr | |
+30.35% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.12% | 17TCr |